Thermo Fisher (TMO) is close to a deal for Solventum’s (SOLV) purification and filtration business, The Wall Street Journal’s Lauren Thomas reports. A transaction, which could be announced as soon as this week, is expected to value the filtration business between $3.5B-$4B, according to people familiar with the matter.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on TMO:
- Thermo Fisher files automatic mixed securities shelf
- Thermo Fisher Expands Board with Healthcare Executive
- Thermo Fisher raises quarterly dividend 10% to 43c per share
- Third Point buys Capital One, cuts Microsoft in Q4
- Trump Trade: President to impose 25% tariffs on steel, aluminum imports